Hawaiian Eye & Retina Meeting

Retina Program

Saturday & Sunday Combined General Sessions

We kick off the week with combined general sessions where attendees can gain insight from the physician, nurse and administrator viewpoints. Saturday conversations will surround a variety of subspecialty areas. Sunday will focus on what’s new this year and how to adapt to the changing ophthalmic practice environment and will also feature the inaugural Lindstrom Leadership Award & Lecture and a special guest speaker presentation and meet & greet. The schedule for Saturday and Sunday can be found under the Comprehensive Ophthalmology Program; these sessions are only approved for CME credit(s) for physicians where indicated and are not approved for CNE credit(s) for nurses or COE credit(s) for administrators.


Sunday, January 16, 2022: Additional Retina Sessions

CME Breakfast Seminar

6:30 am – 7:30 am

Expert Perspectives on Challenging Cases in Neovascular Age-Related Macular Degeneration

  • Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
    Activity Chair: Sophie J. Bakri, MD
    Faculty: Dilsher S. Dhoot, MD; Rishi P. Singh, MD

CME Lunch Seminar

12:00 pm – 1:00 pm

Retina360: Advances in the Management of Retinal Disease

  • Supported by educational grants from Alcon Vision, LLC; Alimera Sciences, Inc.; Bausch + Lomb; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Optos, Inc.; and REGENXBIO, Inc.
    Activity Chair: Rishi P. Singh, MD
    Faculty: Anita Barikian, MD; Dilsher S. Dhoot, MD; Carl D. Regillo, MD; Sumit Sharma, MD; Sunil K. Srivastava, MD; Katherine E. Talcott, MD

Industry Expert Theater Breakfast**

6:30 am – 7:30 am

Exploring the Role of Angiopoietins in Retinal Diseases

  • This educational event is presented by Genentech®.
    Sumit Sharma, MD
    **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

CME GENERAL SESSIONS

Update on Imaging and New Technologies
  • Moderator: Peter K. Kaiser, MD
7:30 am – 7:35 am

Welcome and Announcements

7:35 am – 7:47 am

Interesting Diagnoses made by OCT

  • Steve Yeh, MD
7:47 am – 7:49 am

Q&A

7:49 am – 8:01 am

What’s New in Imaging?

  • SriniVas Sadda, MD
8:01 am – 8:03 am

Q&A

8:03 am – 8:15 am

Diagnosis and Evaluation of GA and Precursor Lesions in AMD

  • Glenn J. Jaffe, MD
8:15 am – 8:17 am

Q&A

8:17 am – 8:29 am

Nonperfusion in Diabetic Retinopthy

  • SriniVas Sadda, MD
8:29 am – 8:31 am

Q&A

8:31 am – 8:43 am

Retinal Imaging: Not Always Clinically Relevant in DME

  • Sophie J. Bakri, MD
8:43 am – 8:45 am

Q&A

8:45 am – 8:57 am

CRVO: What a Photo Can Tell You? New Understandings from Imaging Modalities and How to Optimize Patient Outcomes

  • TBD
8:57 am – 9:00 am

Q&A

BREAK

9:00 am – 9:30 am

Refreshments and Networking in the Exhibit Hall

Update on Imaging and New Technologies (Continued)
  • Moderator: Peter K. Kaiser, MD
9:30 am – 9:42 am

The Impact of Twitter Use Among Academic Ophthalmologists

  • Sunir J. Garg, MD, FACS
9:42 am – 9:45 am

Q&A

9:45 am – 9:57 am

Lifetime Fluorescence Imaging

  • Rishi P. Singh, MD
9:57 am – 10:00 am

Q&A

10:00 am – 10:12 am

Home Monitoring to Detect Onset of CNV: Today and Tomorrow

  • TBD
10:12 am – 10:15 am

Q&A

10:15 am – 10:27 am

Recent Challenges of Artificial Intelligence in Retinal Disease

  • TBD
10:27 am – 10:30 am

Q&A

BREAK

10:30 am – 11:00 am

Refreshments and Networking in the Exhibit Hall

New Treatments for Age-related Macular Degeneration
11:00 am – 12:00 pm

Panel Discussion

  • Moderator: Peter K. Kaiser, MD
    Panelists: Robert L. Avery, MD; Glenn J. Jaffe, MD; Judy E. Kim, MD; Sunir J. Garg, MD; SriniVas Sadda, MD

CME Lunch Seminar

12:00 pm – 1:00 pm

Addressing Anti-VEGF Durability Issues Through Novel Surgical Approaches for the Treatment of nAMD and DME

  • Supported by an educational grant from Genentech, a member of the Roche Group.
    Activity Chair: Carl D. Regillo, MD, FACS
    Faculty: Margaret A. Chang, MD, MS; Dilsher S. Dhoot, MD

INDUSTRY WORKSHOPS**

2:30 pm – 4:30 pm

Practical Training in Equipment, Technology, and Insurance

  • **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

CME Breakfast Seminar

6:30 am – 7:30 am

Optimizing the Management of Retinal Vein Occlusion Through Imaging and Treatment Regimens

  • Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
    Activity Chair: Rishi P. Singh, MD
    Faculty: Yasha Modi, MD; Nathan C. Steinle, MD

GENERAL SESSION

Macular Degeneration
  • Moderator: Carl D. Regillo, MD
7:30 am – 7:35 am

Welcome and Announcements

7:35 am – 7:47 am

Non-Exudative CNVM: What to Look for and How to Manage Them?

  • Caroline R. Baumal, MD, FASRS
7:47 am – 7:52 am

Q&A

7:52 am – 8:04 am

Pegcetacoplan DERBY and OAKS Phase 3 Study Results

  • Caroline R. Baumal, MD, FASRS
8:04 am – 8:09 am

Q&A

8:09 am – 8:21 am

Biosimilars in Retinal Disease

  • Robert L. Avery, MD
8:21 am – 8:26 am

Q&A

8:26 am – 8:38 am

CATT in 2022: Are the Results Still Relevant?

  • Glenn J. Jaffe, MD
8:38 am – 8:43 am

Q&A

8:43 am – 8:55 am

OCT Risk Factors for Late AMD: Implications for Clinical Practice

  • SriniVas Sadda, MD
8:55 am – 9:00 am

Q&A

9:00 am – 9:30 am

Refreshments and Networking in the Exhibit Hall

Macular Degeneration (Continued)
  • Moderator: Carl D. Regillo, MD
9:30 am – 9:42 am

Faricimab for nAMD Phase 3 TENAYA and LUCERNE Studies

  • Rishi P. Singh, MD
9:42 am – 9:45 am

Q&A

9:45 am – 9:57 am

Update on the Port Delivery System for nAMD

  • Carl D. Regillo, MD
9:57 am – 10:00 am

Q&A

10:00 am – 10:12 am

Gene Therapy for Exudative AMD

  • Lejla Vajzovic, MD
10:12 am – 10:15 am

Q&A

10:15 am – 10:27 am

Aqueous Chlorhexidine Compared with Povidone-iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial

  • Sunir J. Garg, MD, FACS
10:27 am – 10:30 am

Q&A

BREAK

10:30 am – 11:00 am

Refreshments and Networking in the Exhibit Hall

Macular Degeneration (Continued)
11:00 am – 12:00 pm

Panel Discussion

  • Moderator: Carl D. Regillo, MD
    Panelists: Robert L. Avery, MD; Sunir J. Garg, MD, FACS; Glenn J. Jaffe, MD; SriniVas Sadda, MD; Basil K. Williams Jr, MD

CME Lunch Seminar

12:00 pm – 1:00 pm

Diabetic Macular Edema: Inflammatory Markers and Their Role as Potential Therapeutic Targets

  • Supported by an educational grant from AbbVie Inc.
    Activity Chair: Peter K. Kaiser, MD
    Faculty: Michael S. Ip, MD; Judy E. Kim, MD, FARVO, FASRS

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

CME Sunset Seminar

5:30 pm – 6:30 pm

NMOSD Management: Rise of the Biologics

  • Supported by an educational grant from Genentech, a member of the Roche Group
    Activity Chair: Prem S. Subramanian, MD, PhD
    Faculty: Andrew G. Lee, MD

CME Breakfast Seminar

6:30 am – 7:30 am

Case Challenges: Early Interventions and Treatment Protocols in Patients With Diabetic Retinopathy

  • Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
    Activity Chair: Jorge A. Fortun, MD
    Faculty: Peter K. Kaiser, MD; Yasha Modi, MD

CME GENERAL SESSION

Diabetic Retinopathy and Retinal Vascular Disease
  • Moderator: Michael S. Ip, MD
7:30 am – 7:35 am

Welcome and Announcements

7:35 am – 7:47 am

Diabetic Tractional Detachments: Surgical Management Tips

  • Rishi P. Singh, MD
7:47 am – 7:49 am

Q&A

7:49 am – 8:01 am

Diabetic Retinopathy Screening: A Different Approach

  • Yasha S. Modi, MD
8:01 am – 8:03 am

Q&A

8:03 am – 8:15 am

Update on Brolucizumab for DME

  • Michael S. Ip, MD
8:15 am – 8:17 am

Q&A

8:17 am – 8:29 am

Update on Faricumab for DME

  • Caroline R. Baumal, MD, FASRS
8:29 am – 8:31 am

Q&A

8:31 am – 8:43 am

Update from the DRCR Retina Network

  • Judy E. Kim, MD
8:43 am – 8:45 am

Q&A

8:45 am – 8:57 am

OCTA Imaging of Diabetic Retinopathy

  • Anita Barikian, MD, FASRS, FAAO
8:57 am – 9:00 am

Q&A

BREAK

9:00 am – 9:30 am

Refreshments and Networking in the Exhibit Hall

Diabetic Retinopathy and Retinal Vascular Disease (Continued)
  • Moderator: Michael S. Ip, MD
9:30 am – 9:42 am

Treatment for Central Retinal Vein Occlusion: Does Fluid Status Matter?

  • Michael S. Ip, MD
9:42 am – 9:45 am

Q&A

9:45 am – 9:57 am

Management of Vitreous Hemorrhage from Proliferative Diabetic Retinopathy

  • Katherine E. Talcott, MD
9:57 am – 10:00 am

Q&A

10:00 am – 10:12 am

Gene Therapy for Diabetic Retinopathy Severity

  • Michael S. Ip, MD
10:12 am – 10:15 am

Q&A

10:15 am – 10:27 am

Lost to Follow-up and Diabetic Retinopathy

  • Katherine E. Talcott, MD
10:27 am – 10:30 am

Q&A

BREAK

10:30 am – 11:00 am

Refreshments and Networking in the Exhibit Hall

Diabetic Retinopathy and Retinal Vascular Disease (Continued)
  • Moderator: Michael S. Ip, MD
11:00 am – 12:00 pm

Retinal Vascular Disease Panel Discussion

  • Moderator: Michael S. Ip, MD
    Panelists: Robert L. Avery, MD; Yasha S. Modi, MD; Judy E. Kim, MD; Katherine E. Talcott, MD

CME Lunch Seminar

12:00 pm – 1:00 pm

Tie2 Activation as an Approach to Retinal Disease Treatment: New Perspectives

  • Supported by an educational grant from Genentech, a member of the Roche Group.
    Activity Chair: Judy E. Kim, MD, FARVO, FASRS
    Faculty: Rishi P. Singh, MD

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Industry Expert Theater Breakfast**

6:30 am – 7:30 am

A Case Series: Identifying Opportunities for Integration

  • This promotional educational event is presented by Allergan, an AbbVie company.
    Moderator: Caroline R. Baumal, MD
    Faculty: Michael S. Ip, MD; Yasha S. Modi, MD; Sunil K. Srivastava, MD
    **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

GENERAL SESSION

Pediatric Retina, Uveitis, Endophthalmitis and Tumors
  • Moderator: Caroline R. Baumal, MD, FASRS
7:30 am – 7:35 am

Welcome and Announcements

7:35 am – 7:47 am

Surgical Management of Pediatric Retinal Detachment

  • Caroline R. Baumal, MD, FASRS
7:47 am – 7:49 am

Q&A

7:49 am – 8:01 am

Pediatric Epiretinal Membranes: Differential Diagnosis and Management

  • Lejla Vajzovic, MD
8:01 am – 8:03 am

Q&A

8:03 am – 8:15 am

Management of Pediatric and Adult-onset Coats Disease

  • Caroline R. Baumal, MD, FASRS
8:15 am – 8:17 am

Q&A

8:17 am – 8:29 am

What Do We Expect to See after Radiation for Choroidal Melanoma

  • Basil K. Williams Jr, MD
8:29 am – 8:31 am

Q&A

8:31 am – 8:43 am

Retinal Side Effects after Chemotherapy

  • William F. Mieler, MD
8:43 am – 8:45 am

Q&A

8:45 am – 8:57 am

Indications and Approach to Biopsy of Intraocular Tumors

  • Basil K. Williams Jr, MD
8:57 am – 9:00 am

Q&A

BREAK

9:00 am – 9:30 am

Refreshments and Networking in the Exhibit Hall

Pediatric Retina, Uveitis and Tumors (Continued)
  • Moderator: Caroline R. Baumal, MD, FASRS
9:30 am – 9:42 am

Do Not Miss These Diagnoses!

  • Steven Yeh, MD
9:42 am – 9:45 am

Q&A

9:45 am – 9:57 am

Imaging Pearls for Uveitis

  • Yasha S. Modi, MD
9:57 am – 10:00 am

Q&A

10:00 am – 10:12 am

My Best Uveitis Cases

  • Glenn J. Jaffe, MD
10:12 am – 10:15 am

Q&A

10:15 am – 10:27 am

Learn from My Mistakes in Uveitis Cases

  • Sunil K. Srivastava, MD
10:27 am – 10:30 am

Q&A

BREAK

10:30 am – 11:00 am

Refreshments and Networking in the Exhibit Hall

Inherited Retinal Disease and Gene Therapy Update
  • Moderator: Caroline R. Baumal, MD, FASRS
11:00 am – 11:12 am

Inherited Retinal Disease Fascinomas

  • William F. Mieler, MD
11:12 am – 11:15 am

Q&A

11:15 am – 11:27 am

Practical Considerations for Subretinal Gene Therapy Delivery

  • Lejla Vajzovic, MD
11:27 am – 11:30 am

Q&A

11:30 am – 11:42 am

What’s the Right Dose of Anti-VEGF for Pediatric Patients?

  • Robert L. Avery, MD
11:42 am – 11:45 am

Q&A

11:45 am – 11:57 am

Update on Gene Therapy for Inherited Retinal Disease

  • Lejla Vajzovic, MD
11:57 am – 12:00 pm

Q&A

CME Lunch Seminar

12:00 pm – 1:00 pm

Geographic Atrophy: Emerging Treatment Options That Focus on the Complement Cascade

  • Supported by an educational grant from Apellis.
    Activity Chair: Nathan C. Steinle, MD
    Faculty: Caroline Baumal, MD; Lejla Vajzovic, MD, FASRS

FAMILY-FRIENDLY ACTIVITY*

2:00 pm – 3:00 pm

Announcement Coming Soon!

  • *This session is not approved for AMA PRA Category 1 Credit(s)™.

CME BANYAN TREE SESSION

4:15 pm – 5:15 pm

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

HAWAIIAN LUAU*

6:30 pm – 8:00 pm

Join your colleagues on a journey through the legends and history of Hawaii complete with stories, drumbeats, folk music, hula dancing and fire performers. This event is open to all attendees and their guests; an additional fee is required – please register directly with the resort (select Thursday, January 20, 2022 to be with our group).

  • *This session is not approved for AMA PRA Category 1 Credit(s)™.

CME Breakfast Seminar

6:30 am – 7:30 am

X-Linked Retinitis Pigmentosa and Gene Therapy: More Than Meets the Eye

  • Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Global Services, LLC
    Activity Chair: Yasha Modi, MD
    Faculty: Lejla Vajzovic, MD

CME GENERAL SESSION

Surgery Update
  • Moderator: Sophie J. Bakri, MD
7:30 am – 7:35 am

Welcome and Announcements

7:35 am – 7:47 am

Techniques for PVR Surgery

  • Carl D. Regillo, MD
7:47 am – 7:52 am

Q&A

7:52 am – 8:04 am

Management of Submacular Hemorrhage

  • Sophie J. Bakri, MD
8:04 am – 8:09 am

Q&A

8:09 am – 8:20 am

Controversies in the Management of Posterior Segment Open-globe Injuries

  • William F. Mieler, MD
8:20 am – 8:25 am

Q&A

8:25 am – 8:37 am

Vitreoretinal Surgery Techniques for Infectious and Inflammatory Retinal Diseases

  • Sunil K. Srivastava, MD
8:37 am – 8:42 am

Q&A

8:42 am – 8:54 am

Hypersonic Vitrectomy

  • Sunir J. Garg, MD, FACS
8:54 am – 9:00 am

Q&A

BREAK

9:00 am – 9:30 am

Refreshments and Networking in the Exhibit Hall

Vitreoretinal Surgical Pearls
9:30 am – 10:29 am

Panel Discussion

  • Moderator: Sophie J. Bakri, MD
    Panelists: Sunir J. Garg, MD, FACS; William F. Mieler, MD; Sunil K. Srivastava, MD; Lejla Vajzovic, MD; Steven Yeh, MD

BREAK

10:30 am – 11:00 am

Refreshments and Networking in the Exhibit Hall

Best Cases of 2021
11:00 am – 12:00 pm

Case Presentations and Panel Discussion

  • Moderator: Sophie J. Bakri, MD
    Panelists: Glenn J. Jaffe, MD; William F. Mieler, MD; Sunil K. Srivastava, MD; Steven Yeh, MD
12:00 pm

Meeting Concludes